Corona vaccine closer to success, Oxford vaccine boosts people’s immunity
Although preliminary results from Oxford’s corona vaccine trial have not yet been officially released, university professor Andrew Pollard said in a recent research conference that positive results have been found.
LONDON: People who have been given doses of the corona vaccine for testing have developed strong immunity, Oxford University said on Tuesday. Oxford University is developing the corona vaccine in collaboration with the UK pharmaceutical company AstraZeneca. Although preliminary results of the test have not yet been officially released, university professor Andrew Pollard said at a recent Acresearch conference that positive results have been found.
A statement from Oxford University stated that “Professor Pollard was referring to the second phase of security and the immune system.” At this stage, trials have been conducted in the UK on people aged 56 to 69 and over 70 years. The third phase of clinical trials of the AstraZeneca vaccine on humans is underway. It remains at the forefront of the vaccine race. It is believed that it will hit the market soon.
Preliminary results of vaccine showed an effective result on the elderly
The Corona epidemic is a relief news amid the ongoing war. The corona vaccine from Oxford University, which is being developed in collaboration with the British pharmaceutical company AstraZeneca, has come closer to success. The vaccine, which is in the final stages of testing, has been found to be as effective in the elderly as it is in the young. Given the weakening of the immune system with age, this effect of the vaccine on the elderly is encouraging. Meanwhile, the newspaper ‘The Sun’ quoted the staff of a large hospital trust in London as saying that the hospitals have been instructed to be ready for vaccination from November 2. It will be a great relief for the global economy struggling with Corona to get the vaccine on the market as soon as possible.
A spokeswoman for AstraZeneca said: “It is encouraging that the vaccine has had a similar effect on both young and old. At the same time, its side effects have been shown less in the elderly. These results provide further evidence that the vaccine is safe and effective. The body’s immunity decreases with age. That is why the number of elderly people who have lost their lives due to the virus is high. The good news is that even in the elderly, a better immune response is created with the help of vaccines. If this vaccine continues to be effective, it will help the world battling the epidemic to return to normal as soon as possible.
This vaccine from Oxford is in the final stages of testing. Preliminary results will be published soon. AstraZeneca has so far agreed to supply vaccines to many countries. Meanwhile, British Health Minister Matt Hancock expects the vaccine to hit the market in early 2021. However, he did not rule out the possibility of a vaccine this year.
